BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
270.10
-9.83 (-3.51%)
At close: Jun 5, 2026, 4:00 PM EDT
269.09
-1.01 (-0.38%)
After-hours: Jun 5, 2026, 7:57 PM EDT
BeOne Medicines AG Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4,792 | 4,548 | 2,627 | 3,183 | 3,870 | 4,376 |
Short-Term Investments | - | - | - | 2.6 | 665.25 | 2,242 |
Cash & Short-Term Investments | 4,792 | 4,548 | 2,627 | 3,186 | 4,535 | 6,618 |
Cash Growth | 90.42% | 73.08% | -17.53% | -29.75% | -31.47% | 42.29% |
Accounts Receivable | 938.02 | 865.08 | 676.28 | 358.03 | 173.17 | 483.11 |
Inventory | 681.59 | 608.23 | 494.99 | 416.12 | 282.35 | 242.63 |
Other Current Assets | 190 | 212.75 | 192.92 | 243.39 | 216.55 | 270.17 |
Total Current Assets | 6,601 | 6,234 | 3,992 | 4,203 | 5,207 | 7,614 |
Net Property, Plant & Equipment | 1,786 | 1,790 | 1,718 | 1,419 | 955.91 | 705.04 |
Other Intangible Assets | 61.68 | 62.7 | 51.1 | 57.14 | 40.62 | 46.68 |
Other Long-Term Assets | 104.24 | 102.42 | 160.49 | 125.36 | 175.69 | 169.93 |
Total Assets | 8,554 | 8,189 | 5,921 | 5,805 | 6,379 | 8,536 |
Accounts Payable | 423.55 | 479.04 | 405 | 315.11 | 294.78 | 262.4 |
Accrued Expenses | 1,079 | 1,109 | 803.71 | 693.73 | 467.35 | 558.06 |
Short-Term Debt | 116.14 | 57.29 | 851.53 | 688.37 | 328.97 | 427.57 |
Current Portion of Long-Term Debt | 72.74 | 56.71 | - | - | - | - |
Current Portion of Leases | 20.58 | 20.7 | 17.58 | 21.95 | 24.04 | 21.93 |
Unearned Revenue | - | - | - | - | 213.86 | 187.41 |
Other Current Liabilities | 99.22 | 105.97 | 137.08 | 90.96 | 139.52 | 142.2 |
Total Current Liabilities | 1,812 | 1,829 | 2,215 | 1,810 | 1,469 | 1,600 |
Long-Term Debt | 1,794 | 1,812 | 166.48 | 197.62 | 209.15 | 202.11 |
Long-Term Leases | 49.67 | 52.94 | 44.28 | 22.25 | 34.52 | 43.04 |
Other Long-Term Liabilities | 137.82 | 133.45 | 163.03 | 237.97 | 283.74 | 558.25 |
Total Long-Term Liabilities | 1,982 | 1,999 | 373.79 | 457.84 | 527.41 | 803.41 |
Total Liabilities | 3,793 | 3,827 | 2,589 | 2,268 | 1,996 | 2,403 |
Common Stock | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.13 |
Additional Paid-in Capital | 12,906 | 12,759 | 12,088 | 11,599 | 11,541 | 11,191 |
Accumulated Other Comprehensive Income | -53.48 | -78.18 | -148.99 | -99.45 | -77.42 | 17.95 |
Retained Earnings | -8,093 | -8,320 | -8,607 | -7,962 | -7,080 | -5,077 |
Shareholders' Equity | 4,760 | 4,361 | 3,332 | 3,537 | 4,383 | 6,133 |
Total Liabilities & Equity | 8,554 | 8,189 | 5,921 | 5,805 | 6,379 | 8,536 |
Total Debt | 2,053 | 2,000 | 1,080 | 930.19 | 596.68 | 694.64 |
Net Cash (Debt) | 2,738 | 2,548 | 1,548 | 2,256 | 3,938 | 5,923 |
Net Cash Growth | 7.48% | 64.63% | -31.39% | -42.73% | -33.51% | 44.86% |
Net Cash Per Share | 23.90 | 22.46 | 14.70 | 21.61 | 38.19 | 63.84 |
Book Value | 4,760 | 4,361 | 3,332 | 3,537 | 4,383 | 6,133 |
Book Value Per Share | 41.56 | 38.44 | 31.65 | 33.89 | 42.50 | 66.09 |
Tangible Book Value | 4,699 | 4,298 | 3,281 | 3,480 | 4,343 | 6,086 |
Tangible Book Value Per Share | 41.02 | 37.89 | 31.16 | 33.34 | 42.11 | 65.59 |